D
BioSig Technologies, Inc.
BSGM
$0.736
-$0.0016-0.22%
D
Sell
12/27/2024Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D- from E+ on 12/27/2024 due to an increase in the valuation index and volatility index.
BioSig Technologies, Inc. (BSGM) was upgraded to D- from E+ on 12/27/2024 due to an increase in the valuation index and volatility index.
E
Sell
3/14/2023Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index.
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/9/2023Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
BioSig Technologies, Inc. (BSGM) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.05 to 0.19, and the quick ratio declined from 2.67 to 0.37.
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.05 to 0.19, and the quick ratio declined from 2.67 to 0.37.
D
Sell
5/18/2022Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 5/18/2022 due to a noticeable increase in the growth index and volatility index. EBIT increased 10.38% from -$9M to -$8.07M, and earnings per share increased from -$0.2442 to -$0.2213.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 5/18/2022 due to a noticeable increase in the growth index and volatility index. EBIT increased 10.38% from -$9M to -$8.07M, and earnings per share increased from -$0.2442 to -$0.2213.
D
Sell
5/5/2022Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D- from E+ on 05/05/2022.
BioSig Technologies, Inc. (BSGM) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D- on 04/20/2022.
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D- on 04/20/2022.
D
Sell
4/18/2022Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 4/18/2022 due to a large decline in the growth index, total return index and solvency index. Total revenue declined 92.59% from $108 to $8, the quick ratio declined from 6.86 to 4.53, and earnings per share declined from -$0.2081 to -$0.2442.
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 4/18/2022 due to a large decline in the growth index, total return index and solvency index. Total revenue declined 92.59% from $108 to $8, the quick ratio declined from 6.86 to 4.53, and earnings per share declined from -$0.2081 to -$0.2442.
D
Sell
11/9/2021Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
BioSig Technologies, Inc. (BSGM) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
E
Sell
11/8/2021Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 5.77 to 4.64.
BioSig Technologies, Inc. (BSGM) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 5.77 to 4.64.
D
Sell
5/18/2021Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 5/18/2021 due to a noticeable increase in the growth index and volatility index. EBIT increased 21.7% from -$10.93M to -$8.56M, and earnings per share increased from -$0.3329 to -$0.2635.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 5/18/2021 due to a noticeable increase in the growth index and volatility index. EBIT increased 21.7% from -$10.93M to -$8.56M, and earnings per share increased from -$0.3329 to -$0.2635.
D
Sell
4/26/2021Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 4/26/2021 due to a decline in the total return index.
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 4/26/2021 due to a decline in the total return index.
D
Sell
3/16/2021Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 3/16/2021 due to an increase in the growth index and total return index. EBIT increased 16.55% from -$13.1M to -$10.93M, earnings per share increased from -$0.3833 to -$0.3329, and operating cash flow increased 2.7% from -$6.27M to -$6.1M.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 3/16/2021 due to an increase in the growth index and total return index. EBIT increased 16.55% from -$13.1M to -$10.93M, earnings per share increased from -$0.3833 to -$0.3329, and operating cash flow increased 2.7% from -$6.27M to -$6.1M.
D
Sell
3/15/2021Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 3/15/2021 due to a decline in the total return index and volatility index.
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 3/15/2021 due to a decline in the total return index and volatility index.
D
Sell
2/18/2021Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 2/18/2021 due to an increase in the total return index.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 2/18/2021 due to an increase in the total return index.
D
Sell
1/25/2021Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 1/25/2021 due to a decline in the valuation index, total return index and volatility index.
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 1/25/2021 due to a decline in the valuation index, total return index and volatility index.
D
Sell
1/8/2021Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 1/8/2021 due to an increase in the valuation index.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 1/8/2021 due to an increase in the valuation index.
D
Sell
12/18/2020Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 12/18/2020 due to a noticeable decline in the efficiency index, volatility index and total return index. Total capital declined 17.06% from $36.64M to $30.39M.
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 12/18/2020 due to a noticeable decline in the efficiency index, volatility index and total return index. Total capital declined 17.06% from $36.64M to $30.39M.
D
Sell
4/22/2020Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 4/22/2020 due to an increase in the volatility index.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 4/22/2020 due to an increase in the volatility index.
D
Sell
3/23/2020Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 3/23/2020 due to a significant decline in the total return index, volatility index and growth index. EBIT declined 176.85% from -$5.5M to -$15.24M, and earnings per share declined from -$0.2498 to -$0.6604.
BioSig Technologies, Inc. (BSGM) was downgraded to D- from D on 3/23/2020 due to a significant decline in the total return index, volatility index and growth index. EBIT declined 176.85% from -$5.5M to -$15.24M, and earnings per share declined from -$0.2498 to -$0.6604.
D
Sell
10/8/2019Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 10/8/2019 due to a decline in the total return index.
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 10/8/2019 due to a decline in the total return index.
D
Sell
9/18/2019Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 9/18/2019 due to an increase in the total return index.
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 9/18/2019 due to an increase in the total return index.
D
Sell
8/13/2019Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 8/13/2019 due to a decline in the growth index, total return index and valuation index. EBIT declined 35.96% from -$5.88M to -$7.99M, operating cash flow declined 16.94% from -$3.52M to -$4.12M, and earnings per share declined from -$0.3294 to -$0.3848.
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 8/13/2019 due to a decline in the growth index, total return index and valuation index. EBIT declined 35.96% from -$5.88M to -$7.99M, operating cash flow declined 16.94% from -$3.52M to -$4.12M, and earnings per share declined from -$0.3294 to -$0.3848.
D
Sell
4/16/2019Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 4/16/2019 due to a substantial increase in the total return index, efficiency index and growth index. Total capital increased 190.94% from $3.8M to $11.05M, and earnings per share increased from -$0.3481 to -$0.33.
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 4/16/2019 due to a substantial increase in the total return index, efficiency index and growth index. Total capital increased 190.94% from $3.8M to $11.05M, and earnings per share increased from -$0.3481 to -$0.33.
D
Sell
7/27/2018Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 7/27/2018 due to a substantial decline in the growth index and valuation index. EBIT declined 118.69% from -$2.64M to -$5.77M, earnings per share declined from -$0.0983 to -$0.18, and operating cash flow declined 0.95% from -$2.39M to -$2.41M.
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 7/27/2018 due to a substantial decline in the growth index and valuation index. EBIT declined 118.69% from -$2.64M to -$5.77M, earnings per share declined from -$0.0983 to -$0.18, and operating cash flow declined 0.95% from -$2.39M to -$2.41M.
D
Sell
5/7/2018Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 5/7/2018 due to a significant decline in the efficiency index and valuation index.
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 5/7/2018 due to a significant decline in the efficiency index and valuation index.
C
Hold
4/5/2018Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 4/5/2018 due to an increase in the volatility index and total return index.
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 4/5/2018 due to an increase in the volatility index and total return index.
D
Sell
2/28/2018Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 2/28/2018 due to a noticeable decline in the growth index. EBIT declined 165.09% from -$1.91M to -$5.07M, earnings per share declined from -$0.0699 to -$0.1646, and operating cash flow declined 27.89% from -$1.76M to -$2.25M.
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 2/28/2018 due to a noticeable decline in the growth index. EBIT declined 165.09% from -$1.91M to -$5.07M, earnings per share declined from -$0.0699 to -$0.1646, and operating cash flow declined 27.89% from -$1.76M to -$2.25M.
C
Hold
12/13/2017Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 12/13/2017 due to an increase in the total return index.
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 12/13/2017 due to an increase in the total return index.
D
Sell
11/28/2017Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 11/28/2017 due to a decline in the total return index and volatility index.
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 11/28/2017 due to a decline in the total return index and volatility index.
C
Hold
11/13/2017Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 11/13/2017 due to a major increase in the growth index. Earnings per share increased from -$0.1234 to -$0.07, EBIT increased 36.58% from -$3.02M to -$1.91M, and operating cash flow increased 4.36% from -$1.84M to -$1.76M.
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 11/13/2017 due to a major increase in the growth index. Earnings per share increased from -$0.1234 to -$0.07, EBIT increased 36.58% from -$3.02M to -$1.91M, and operating cash flow increased 4.36% from -$1.84M to -$1.76M.
D
Sell
5/10/2017Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 5/10/2017 due to a major decline in the growth index. Earnings per share declined from -$0.0653 to -$0.143, EBIT declined 64.82% from -$1.76M to -$2.9M, and operating cash flow declined 27.47% from -$1.26M to -$1.61M.
BioSig Technologies, Inc. (BSGM) was downgraded to D+ from C- on 5/10/2017 due to a major decline in the growth index. Earnings per share declined from -$0.0653 to -$0.143, EBIT declined 64.82% from -$1.76M to -$2.9M, and operating cash flow declined 27.47% from -$1.26M to -$1.61M.
C
Hold
2/1/2017Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 2/1/2017 due to a noticeable increase in the total return index and growth index.
BioSig Technologies, Inc. (BSGM) was upgraded to C- from D+ on 2/1/2017 due to a noticeable increase in the total return index and growth index.
D
Sell
11/17/2016Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 11/17/2016 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.3243 to -$0.08, EBIT increased 71.91% from -$5.54M to -$1.55M, and operating cash flow increased 32.54% from -$1.6M to -$1.08M.
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 11/17/2016 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.3243 to -$0.08, EBIT increased 71.91% from -$5.54M to -$1.55M, and operating cash flow increased 32.54% from -$1.6M to -$1.08M.
D
Sell
8/12/2016Downgrade
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 8/12/2016 due to a decline in the growth index. EBIT declined 139.18% from -$2.31M to -$5.54M, earnings per share declined from -$0.1532 to -$0.3243, and operating cash flow declined 36.9% from -$1.17M to -$1.6M.
BioSig Technologies, Inc. (BSGM) was downgraded to D from D+ on 8/12/2016 due to a decline in the growth index. EBIT declined 139.18% from -$2.31M to -$5.54M, earnings per share declined from -$0.1532 to -$0.3243, and operating cash flow declined 36.9% from -$1.17M to -$1.6M.
D
Sell
5/12/2016Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 5/12/2016 due to a noticeable increase in the growth index and efficiency index.
BioSig Technologies, Inc. (BSGM) was upgraded to D+ from D on 5/12/2016 due to a noticeable increase in the growth index and efficiency index.
D
Sell
11/2/2015Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 11/2/2015 due to a significant increase in the efficiency index, solvency index and valuation index. Net income increased 55.96% from -$3.05M to -$4.76M.
BioSig Technologies, Inc. (BSGM) was upgraded to D from D- on 11/2/2015 due to a significant increase in the efficiency index, solvency index and valuation index. Net income increased 55.96% from -$3.05M to -$4.76M.
D
Sell
7/1/2015Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to D- from E+ on 7/1/2015 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 0.2 to 0.3.
BioSig Technologies, Inc. (BSGM) was upgraded to D- from E+ on 7/1/2015 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 0.2 to 0.3.
E
Sell
4/1/2015Upgraded
BioSig Technologies, Inc. (BSGM) was upgraded to E+ from E on 4/1/2015 due to a significant increase in the efficiency index, growth index and total return index. Total capital increased 104.62% from -$426.2 to -$872.1.
BioSig Technologies, Inc. (BSGM) was upgraded to E+ from E on 4/1/2015 due to a significant increase in the efficiency index, growth index and total return index. Total capital increased 104.62% from -$426.2 to -$872.1.
E
Sell
1/27/2015None
BioSig Technologies, Inc. (BSGM) was downgraded to E from U on 01/27/2015.
BioSig Technologies, Inc. (BSGM) was downgraded to E from U on 01/27/2015.
NASDAQ
03/12/2025 3:59PM Eastern
Quotes delayed
